Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11277614rdf:typepubmed:Citationlld:pubmed
pubmed-article:11277614lifeskim:mentionsumls-concept:C1155003lld:lifeskim
pubmed-article:11277614lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:11277614lifeskim:mentionsumls-concept:C1516451lld:lifeskim
pubmed-article:11277614lifeskim:mentionsumls-concept:C1514623lld:lifeskim
pubmed-article:11277614lifeskim:mentionsumls-concept:C0965594lld:lifeskim
pubmed-article:11277614lifeskim:mentionsumls-concept:C1176299lld:lifeskim
pubmed-article:11277614pubmed:issue1lld:pubmed
pubmed-article:11277614pubmed:dateCreated2001-3-30lld:pubmed
pubmed-article:11277614pubmed:abstractTextMembers of the imidazoquinoline molecule family, including imiquimod and resiquimod (R-848), have potent antiviral and antitumor activities. Imiquimod cream (5%) (Aldara) is currently indicated for treatment of external genital and perianal warts. Previous characterization of these compounds has focused upon their ability to activate monocytes and dendritic cells, but recent studies have shown that resiquimod also stimulates B lymphocytes to proliferate and express an activated phenotype. This suggests that resiquimod could potentially serve as an effective vaccine adjuvant in stimulating a humoral immune response. This study shows that resiquimod mimics effects of the T-dependent CD40 signal in both mouse and human B cell lines. Resiquimod, like CD40, stimulates antibody secretion, cytokine production, protection from apoptosis, and CD80 upregulation. In addition, it shows synergy with signals delivered by the B cell antigen receptor and heightens CD40-mediated B cell activation, demonstrating that resiquimod can enhance antigen-specific responses in B lymphocytes.lld:pubmed
pubmed-article:11277614pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:languageenglld:pubmed
pubmed-article:11277614pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:citationSubsetIMlld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11277614pubmed:statusMEDLINElld:pubmed
pubmed-article:11277614pubmed:monthFeblld:pubmed
pubmed-article:11277614pubmed:issn0008-8749lld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:BishopG AGAlld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:TomaiM AMAlld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:RamirezL MLMlld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:BaccamMMlld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:BuschL KLKlld:pubmed
pubmed-article:11277614pubmed:authorpubmed-author:PedersonL KLKlld:pubmed
pubmed-article:11277614pubmed:copyrightInfoCopyright 2001 Academic Press.lld:pubmed
pubmed-article:11277614pubmed:issnTypePrintlld:pubmed
pubmed-article:11277614pubmed:day25lld:pubmed
pubmed-article:11277614pubmed:volume208lld:pubmed
pubmed-article:11277614pubmed:ownerNLMlld:pubmed
pubmed-article:11277614pubmed:authorsCompleteYlld:pubmed
pubmed-article:11277614pubmed:pagination9-17lld:pubmed
pubmed-article:11277614pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:meshHeadingpubmed-meshheading:11277614...lld:pubmed
pubmed-article:11277614pubmed:year2001lld:pubmed
pubmed-article:11277614pubmed:articleTitleThe immune response modifier resiquimod mimics CD40-induced B cell activation.lld:pubmed
pubmed-article:11277614pubmed:affiliationDepartment of Microbiology, VA Medical Center, Iowa City, Iowa 52242, USA. gail-bishop@uiowa.edulld:pubmed
pubmed-article:11277614pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11277614pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11277614pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11277614pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11277614lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11277614lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11277614lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11277614lld:pubmed